Compliance triage (pre-launch) — ChatGPT Ads India glossary
In plain English: before a healthcare client's ChatGPT Ads campaign ever goes live, every headline, claim, and targeting choice gets sorted into "fine as is," "needs a rewrite," or "cannot run" — so nothing surprising shows up after real budget is already spending.
Definition
Pre-launch compliance triage is a structured, three-way sort applied to every element of a healthcare advertiser's proposed ChatGPT Ads campaign before launch: each creative line, each targeting parameter, and each underlying claim is reviewed and marked clear, needs-rewrite, or blocked. The review checks against NMC Section 6 (restrictions on physician advertising and self-promotion), ASCI Chapter III (health, wellness and nutraceutical claim substantiation), the DPDP Act (consent and personal-data-use disclosures), and, where the advertiser's category requires it, the ART (Regulation) Act 2021 for fertility clinics, DCGI/UCPMP 2024 for pharma, or AYUSH Ministry advertising guidance for Ayurveda, Yoga, Unani, Siddha and Homeopathy brands. It happens before submission to OpenAI's own ad review, not instead of it — the two checks cover different risks and neither substitutes for the other.
Why it matters for Indian healthcare marketers
The single biggest misunderstanding new ChatGPT Ads advertisers bring to healthcare is assuming that platform approval equals full compliance. It doesn't. OpenAI's ad review checks its own global safety and content standards — things like misinformation, unsafe medical claims by its own definition, and platform-wide policy — but it has no visibility into, and makes no attempt to check, India-specific statutes like NMC Section 6's limits on how a named physician can be promoted, or ASCI's substantiation requirements for a wellness outcome claim. A creative can sail through OpenAI's own review and still expose a hospital or clinic to a regulatory notice, an ASCI complaint, or reputational damage the moment it starts running, because the two review systems are simply answering different questions.
This gap matters more for healthcare than almost any other advertiser category on the platform, because Indian healthcare marketing already operates under one of the country's stricter advertising regimes, and the conversational ad format adds a wrinkle static formats didn't have: a single approved opening line can lead into a live, unscripted follow-up exchange with a user, and an advertiser who has only triaged the opening creative — not the likely follow-up branches — can find their own brand voice drifting into a non-compliant claim inside a conversation nobody pre-approved. Skipping or shortcutting pre-launch triage is consistently the single most common reason a healthcare ChatGPT Ads account gets paused mid-flight for a compliance issue that a proper pre-launch pass would have caught for free.
Because this ad format only reached India in mid-2026, there is also no established playbook advertisers can lean on from prior campaigns — triage has to be built specifically for each account's specialty and claim set, not copied from a generic template.
How ICG uses/measures/handles it in a live engagement
ICG runs compliance triage as a mandatory gate before any new healthcare account's first campaign goes live — no creative reaches OpenAI's own submission queue until it has cleared ICG's internal sort. The process moves specialty by specialty: a multi-specialty hospital group's cardiology, fertility, and cosmetic-dermatology creative sets are each triaged against their own applicable rule set (ART Act only applies to the fertility branch, for instance), rather than applying one blanket check across the whole account. Every flagged item gets either a compliant rewrite proposed on the spot or, where no compliant version is realistic, a recommendation to drop that claim or targeting parameter entirely rather than risk a launch delay later.
Triage isn't a one-time gate — ICG re-runs it whenever a client proposes new creative, expands into a new specialty or city, or when NMC, ASCI, or DPDP guidance itself is updated, which has already happened more than once since India's ChatGPT Ads rollout began. This discipline is baked into every account regardless of scope — a larger, multi-specialty account simply has proportionally more creative variants and specialty branches to triage each cycle. Backed by App\Support\NamedExperts::get(). --}}
Related terms
Frequently asked questions
What is pre-launch compliance triage?
It is a structured review ICG runs on a healthcare advertiser's creative, targeting, and claims before a ChatGPT Ads campaign launches, sorting each element into clear, needs-rewrite, or blocked against NMC, ASCI, DPDP, and any category-specific Indian healthcare advertising rules.
Why isn't OpenAI's own ad review enough?
OpenAI's ad policy checks its own global content and safety standards, not India-specific healthcare advertising law. A creative can pass platform review and still violate NMC Section 6's restrictions on physician self-promotion or ASCI Chapter III's claim-substantiation rules, so a separate India-specific triage is required before launch.
What gets flagged most often in triage?
The most common flags are unverifiable outcome claims, named-doctor self-promotion language that brushes against NMC Section 6, missing consent-and-data-use disclosures under the DPDP Act, and — for fertility, pharma, and AYUSH categories — condition-specific restricted claims under the ART Act, UCPMP, or Drugs and Magic Remedies Act.
How long does triage take before a campaign can launch?
A first-time triage on a new healthcare account typically takes ICG two to four working days, depending on how many creative variants and specialty branches are in scope; a clean, previously-vetted account renewing its creative set can turn around in under a day.
Don't find out about a compliance gap after launch.
ICG triages every healthcare creative against NMC, ASCI, DPDP and category-specific rules before it ever reaches OpenAI's review queue.
